| Carmela Duarte, | |
|
3105 Wilson Rd, Bakersfield, CA 93304-5319 | |
| (661) 397-8775 | |
| (661) 397-8286 |
| Full Name | Carmela Duarte |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 3105 Wilson Rd, Bakersfield, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043493455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 112088 (California) | Primary |
| Entity Name | Brightside Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801355482 PECOS PAC ID: 6608262464 Enrollment ID: O20220404000301 |
News Archive
The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.
Critical Diagnostics announced today that it has received CE (Conformité Européenne) Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. The product is indicated for use as an aid in risk stratification of patients with heart failure or acute coronary syndrome. This regulatory milestone marks the first time that an assay has become commercially available for the clinical measurement of the biomarker soluble ST2.
Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.
It seems that it remains debatable whether screening women under 50 years old for breast cancer significantly reduces deaths from the disease.
Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carmela Duarte, 3105 Wilson Rd, Bakersfield, CA 93304-5319 Ph: (661) 397-8775 | Carmela Duarte, 3105 Wilson Rd, Bakersfield, CA 93304-5319 Ph: (661) 397-8775 |
News Archive
The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.
Critical Diagnostics announced today that it has received CE (Conformité Européenne) Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. The product is indicated for use as an aid in risk stratification of patients with heart failure or acute coronary syndrome. This regulatory milestone marks the first time that an assay has become commercially available for the clinical measurement of the biomarker soluble ST2.
Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.
It seems that it remains debatable whether screening women under 50 years old for breast cancer significantly reduces deaths from the disease.
Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.
› Verified 6 days ago
Mrs. Karina Higuera Armendariz, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1300 17th St, Bakersfield, CA 93301 Phone: 661-852-6512 | |
Bernardo Garcia, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3300 Truxtun Ave, Bakersfield, CA 93301 Phone: 661-868-6840 | |
Marcie Teresa Lesser, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3628 Stockdale Hwy, Bakersfield, CA 93309 Phone: 661-322-1021 | |
Edith Cassel, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3628 Stockdale Hwy, Bakersfield, CA 93309 Phone: 661-322-1021 | |
Amy Carlson, M.A., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5801 Sundale Ave, Bakersfield, CA 93309 Phone: 661-827-3100 Fax: 661-396-2961 | |
Maricela Mendoza Zuniga, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5000 Callado Ln # A, Bakersfield, CA 93313 Phone: 805-358-9062 | |
Ms. Jenny Elizabeth Thoman, MS, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 930 Truxtun Ave, Suite 201, Bakersfield, CA 93301 Phone: 661-303-6326 |